We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.02 | -0.68% | 148.54 | 148.99 | 146.86 | 148.18 | 9,756,260 | 00:38:34 |
From Apr 2022 to Apr 2024
By Colin Kellaher
Johnson & Johnson on Wednesday said its board authorized the repurchase of up to $5 billion of common stock.
The New Brunswick, N.J., healthcare giant, which had nearly 2.63 billion shares outstanding at the end of July and sports a market capitalization topping $435 billion, said its shares represent an attractive investment opportunity.
J&J shares fell 2.6% Tuesday amid a broad market selloff and are down about 6% for the year to date.
The company said its net debt is at its lowest level in five years, and that it doesn't plan to take on any debt to fund the buyback program, which has no expiration date.
J&J bought about 5.4 million of its shares during the second quarter, but those purchases were part of a systematic plan to meet the needs of the company's compensation programs.
Shares of J&J rose 0.7% to $162.43 in light premarket trading.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
September 14, 2022 07:03 ET (11:03 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
